We generated F1C57BL6/FVB MMTV‐ErbB2 mice (F1‐Neu+ mice hereafter) that were backcrossed with FVB mice to generate BX‐Neu+ mice, a cohort of mice with more varied breast cancer outcome than genetically homogenous mouse strains. This evidence concerns the gene ERBB2 and breast carcinoma.